Company news
SK Biopharmaceuticals Co., Ltd. news in 2025
SK Biopharmaceuticals Co., Ltd.'s news releases, calls and decks from 2025, newest first.
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
November 26, 2025
SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
November 21, 2025
New SK Life Science, Inc. Survey Reveals Communication Gaps Between Patients and Providers That Can Impact Epilepsy Care Outcomes
October 28, 2025
SK Life Science, Inc. to Host "Illuminating the Path to Added Seizure Reduction" Symposium at the 2025 American Epilepsy Society Annual Meeting
October 24, 2025
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
October 19, 2025
Decks in 2025
- Q2 2025 Earnings Presentation
Earnings · 8 slides · Aug 5, 2025
- Q1 2025 Earnings Presentation
Earnings · 8 slides · May 9, 2025
- Q4 2024 Earnings Presentation
Earnings · 8 slides · Feb 6, 2025